EDAP TMS (EDAP) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

EDAP EDAP TMS

Watchlist

2.470
-0.020-0.80%

Close Nov 22 16:00 ET

91.65MMarket Cap-3996P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

EDAP TMS SA Reports Technical Feasibility of Histotripsy Lesion Generation Using Focal One System
Quiver QuantitativeNov 22 08:12 ET
EDAP Announces Scientific Presentation Highlighting Feasibility of Focal One to Perform Non-thermal Histotripsy Energy Delivery at the 187th Acoustical Society of America Meeting
GlobeNewswireNov 22 08:00 ET
Express News | Edap Announces Scientific Presentation at 2024 Aagl Global Congress Comparing Focal One Hifu Versus Surgery for the Treatment of Deep Infiltrating Endometriosis
ReutersNov 19 08:00 ET
EDAP Announces Scientific Presentation at 2024 AAGL Global Congress Comparing Focal One HIFU Versus Surgery for the Treatment of Deep Infiltrating Endometriosis
GlobeNewswireNov 19 08:00 ET
EDAP TMS S.A. (EDAP) Q3 2024 Earnings Call Transcript Summary
moomoo AINov 8 21:47 ET · Conference Call
Piper Sandler Maintains EDAP TMS(EDAP.US) With Buy Rating, Cuts Target Price to $5
Moomoo NewsNov 8 10:31 ET · Ratings

Comments

Jaguar8

Sep 19 07:22

NEWS

$EDAP TMS (EDAP.US)$
EDAP and Avenda Health Launch World’s First AI-Assisted Focal One® Robotic HIFU Procedures
EDAP TMS SA (Nasdaq: EDAP) and Avenda Health have launched the world's first AI-assisted Focal One® Robotic HIFU procedures for prostate cancer treatment. The collaboration integrates Avenda's FDA-cleared Unfold AI® technology with EDAP's Focal One robotic HIFU platform. Unfold AI creates 3D patient-specific cancer maps, enabling more precise tumor targeting and healthy tissue prese...

Jaguar8

Jul 19 15:16

NEWS

$EDAP TMS (EDAP.US)$
EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis
EDAP TMS SA (Nasdaq: EDAP) announced interim results from its Phase 3 study evaluating robotic High-Intensity Focused Ultrasound (HIFU) therapy for deep infiltrating endometriosis.
The study, involving 60 patients, aimed to assess acute pelvic pain levels. Key findings include:
1. Robotic HIFU therapy maintained an excellent safety profile, confi...

Moomoo AI

Jan 25 18:22

Despite EDAP TMS' promising revenue outlook, it's not boosting its P/S as expected. Shareholders seem skeptical of forecasts, accepting lower selling prices. The steady P/S ratio with the industry hints at anticipated revenue instability, normally a share price booster.